Amgen (MGN) reported Q4 FY 2020 earnings of $3.81 per share (versus $3.64 per share in Q4 FY 2019), beating analysts’ consensus estimate of $3.34 per share.
The company’s quarterly revenues amounted to $6.634 bln (+7.1% y/y), roughly in line with analysts’ consensus estimate of $6.570 bln.
AMGN fell to $235.00 (-2.28%) in pre-market trading.